Tumour model

A2058

Melanoma
XenograftIn vitro

A2058 cells

Human A2058 cells were isolated from an amelanotic melanoma.
The A2058 cell line is a human melanoma cell line derived from a brain metastasis of a patient with malignant melanoma. This cell line is widely used in cancer research due to its high metastatic potential, making it an important model for studying melanoma progression and the mechanisms underlying metastasis. A2058 cells are known to express nerve growth factor (NGF) receptors, which are linked to their aggressive and metastatic characteristics.

Tumour growth in vivo

The cells were collected from a tissue culture flask and injected subcutaneously in the right flank of SCID/CB17 mice*. The resulting tumours were monitored by measuring two diameters with calipers, and extrapolating the volume to a sphere.
The mice bearing A2058 tumours can be treated by intra-peritoneal, intra-venous, intra-tumoral or subcutaneous injection of the compounds. Per os administration is also possible.

Figure 1 (view PDF):
Tumour growth curve of the A2058 WT cells as subcutaneous tumors, Mean ± SEM (n=5)

*Tumorogenesis datas are also available for Athymic Nude mice

Download PDF

Model characteristics

Organism
Human
Tissue of origin
Skin
Pathology
Melanoma
Model type
In vitro, Xenograft
Availability
Off the shelf (time of expansion)

Request this model

Tell us about your compound and your endpoints. Our team confirms feasibility, timelines and study design before any commitment.

Related models

Other models sharing the same tissue of origin.

Model
Organism
Tissue of origin
Pathology
Type
Human
Skin
Cutaneous melanoma
XenograftIn vitro
Human
Skin
Malignant melanoma
XenograftIn vitro
Human
Skin
Melanoma
XenograftIn vitro
Human
Skin
Malignant melanoma
XenograftIn vitro
Human
Skin
Malignant melanoma
XenograftIn vitro
Human
Skin
Amelanotic melanoma
XenograftIn vitro